Financials
Financial year 2025
Gross margin
€ 2.7 million
▲ 304% vs 2024
Profit
Growing€ 1.9 million
▲ 310% vs 2024
Debts
Low€ 2.4 million
▲ 145% vs 2024
SYNAPHARM INDUSTRIAL SYNTHESIS from Grâce-Hollogne, company number BE0465726791, closed financial year 2025 with a result of € 1.9 million after tax. For that financial year SYNAPHARM INDUSTRIAL SYNTHESIS recorded a gross margin of € 2.7 million and equity of € 3.7 million. Compared with financial year 2024, the result moved from € 456,662 to € 1.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
What happened at SYNAPHARM INDUSTRIAL SYNTHESIS?
What happened at SYNAPHARM INDUSTRIAL SYNTHESIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jennifer Gu stepped down as director. NBB
- Mark Thurston stepped down as director. NBB
- YSAPSYN stepped down as director. NBB
- BRANDON LEE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 1.9 million (▲ 310% vs 2024). Source: NBB ↗
- BRANDON LEE became a director. NBB
- Edward Lee stepped down as director. NBB
- Artesyn stepped down as director. NBB
In short
From € 272,917 profit in 2021 to € 1.9 million profit in 2025.
Paid € 1.1 million in corporate taxes since 2021.
Best year ever: 2025, with € 1.9 million profit.
On average € 1.6 million of value added per employee in 2025.
A new publication or filing at SYNAPHARM INDUSTRIAL SYNTHESIS? We notify you, reason included.
Follow SYNAPHARM INDUSTRIAL SYNTHESISNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Edward Lee
Director
since 2024 · until 2026
since 2024 · until 2025
Jennifer Gu
Director
since 2024 · until 2030
Mark Thurston
Director
since 2024 · until 2030
since 2025 · until 2030
BRANDON LEE
Director
since 2026 · until 2030
Establishments
Establishment units
Physical locations of this company
Rue de l'Aéroport 52
4460 Grâce-Hollogne
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
DIGITAL LEAD
€ 245,436 gross margin · 2024
DL INVEST
Athina Logistics
€ -7,525 gross margin · 2024
LOGISTICS IN WALLONIA
€ 654,385 gross margin · 2025
Munlogistic
€ 17,923 gross margin · 2025
+1 more
Details
- Company number
- 0465.726.791
- VAT number
- BE 0465.726.791
- Registered office
- Rue de l'Aéroport 52, 4460 Grâce-Hollogne
- Names & denominations
- SYNAPHARM INDUSTRIAL SYNTHESIS · S.I.S.
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 March 1999
- Peppol
- Active · Active since 20 Jan 2026
- Activities · NACE
Vervaardiging van andere organische chemische basisproducten
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen
Vervaardiging van overige organische chemische basisproducten